img

Global Tuberculosis Vaccine Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tuberculosis Vaccine Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tuberculosis Vaccine Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tuberculosis Vaccine Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Self-Procurement and UNICEF are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tuberculosis Vaccine Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tuberculosis Vaccine Drug key manufacturers include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. Merck, Japan BCG Lab, Serum Institute of India are top 3 players and held % sales share in total in 2022.
Tuberculosis Vaccine Drug can be divided into Immune Vaccine and Therapy Vaccine, etc. Immune Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Tuberculosis Vaccine Drug is widely used in various fields, such as Self-Procurement, UNICEF and Other,, etc. Self-Procurement provides greatest supports to the Tuberculosis Vaccine Drug industry development. In 2022, global % sales of Tuberculosis Vaccine Drug went into Self-Procurement filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tuberculosis Vaccine Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine

Segment by Application


Self-Procurement
UNICEF
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tuberculosis Vaccine Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tuberculosis Vaccine Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tuberculosis Vaccine Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Tuberculosis Vaccine Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tuberculosis Vaccine Drug introduction, etc. Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Tuberculosis Vaccine Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Tuberculosis Vaccine Drug Market Overview
1.1 Tuberculosis Vaccine Drug Product Overview
1.2 Tuberculosis Vaccine Drug Market Segment by Type
1.2.1 Immune Vaccine
1.2.2 Therapy Vaccine
1.3 Global Tuberculosis Vaccine Drug Market Size by Type
1.3.1 Global Tuberculosis Vaccine Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Tuberculosis Vaccine Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Tuberculosis Vaccine Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tuberculosis Vaccine Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Tuberculosis Vaccine Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Tuberculosis Vaccine Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Tuberculosis Vaccine Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Tuberculosis Vaccine Drug Sales Breakdown by Type (2024-2024)
2 Global Tuberculosis Vaccine Drug Market Competition by Company
2.1 Global Top Players by Tuberculosis Vaccine Drug Sales (2024-2024)
2.2 Global Top Players by Tuberculosis Vaccine Drug Revenue (2024-2024)
2.3 Global Top Players by Tuberculosis Vaccine Drug Price (2024-2024)
2.4 Global Top Manufacturers Tuberculosis Vaccine Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tuberculosis Vaccine Drug Market Competitive Situation and Trends
2.5.1 Tuberculosis Vaccine Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tuberculosis Vaccine Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Tuberculosis Vaccine Drug Market
2.8 Key Manufacturers Tuberculosis Vaccine Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tuberculosis Vaccine Drug Status and Outlook by Region
3.1 Global Tuberculosis Vaccine Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Tuberculosis Vaccine Drug Historic Market Size by Region
3.2.1 Global Tuberculosis Vaccine Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Tuberculosis Vaccine Drug Sales in Value by Region (2024-2024)
3.2.3 Global Tuberculosis Vaccine Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Tuberculosis Vaccine Drug Forecasted Market Size by Region
3.3.1 Global Tuberculosis Vaccine Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Tuberculosis Vaccine Drug Sales in Value by Region (2024-2034)
3.3.3 Global Tuberculosis Vaccine Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tuberculosis Vaccine Drug by Application
4.1 Tuberculosis Vaccine Drug Market Segment by Application
4.1.1 Self-Procurement
4.1.2 UNICEF
4.1.3 Other
4.2 Global Tuberculosis Vaccine Drug Market Size by Application
4.2.1 Global Tuberculosis Vaccine Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Tuberculosis Vaccine Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Tuberculosis Vaccine Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tuberculosis Vaccine Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Tuberculosis Vaccine Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Tuberculosis Vaccine Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Tuberculosis Vaccine Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Tuberculosis Vaccine Drug Sales Breakdown by Application (2024-2024)
5 North America Tuberculosis Vaccine Drug by Country
5.1 North America Tuberculosis Vaccine Drug Historic Market Size by Country
5.1.1 North America Tuberculosis Vaccine Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Tuberculosis Vaccine Drug Sales in Value by Country (2024-2024)
5.2 North America Tuberculosis Vaccine Drug Forecasted Market Size by Country
5.2.1 North America Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Tuberculosis Vaccine Drug Sales in Value by Country (2024-2034)
6 Europe Tuberculosis Vaccine Drug by Country
6.1 Europe Tuberculosis Vaccine Drug Historic Market Size by Country
6.1.1 Europe Tuberculosis Vaccine Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Tuberculosis Vaccine Drug Sales in Value by Country (2024-2024)
6.2 Europe Tuberculosis Vaccine Drug Forecasted Market Size by Country
6.2.1 Europe Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Tuberculosis Vaccine Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Tuberculosis Vaccine Drug by Region
7.1 Asia-Pacific Tuberculosis Vaccine Drug Historic Market Size by Region
7.1.1 Asia-Pacific Tuberculosis Vaccine Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Tuberculosis Vaccine Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Tuberculosis Vaccine Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Tuberculosis Vaccine Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Tuberculosis Vaccine Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tuberculosis Vaccine Drug Sales in Value by Region (2024-2034)
8 Latin America Tuberculosis Vaccine Drug by Country
8.1 Latin America Tuberculosis Vaccine Drug Historic Market Size by Country
8.1.1 Latin America Tuberculosis Vaccine Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Tuberculosis Vaccine Drug Sales in Value by Country (2024-2024)
8.2 Latin America Tuberculosis Vaccine Drug Forecasted Market Size by Country
8.2.1 Latin America Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tuberculosis Vaccine Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Tuberculosis Vaccine Drug by Country
9.1 Middle East and Africa Tuberculosis Vaccine Drug Historic Market Size by Country
9.1.1 Middle East and Africa Tuberculosis Vaccine Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Tuberculosis Vaccine Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Tuberculosis Vaccine Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Tuberculosis Vaccine Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tuberculosis Vaccine Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Tuberculosis Vaccine Drug Products Offered
10.1.5 Merck Recent Development
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Company Information
10.2.2 Japan BCG Lab Introduction and Business Overview
10.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Products Offered
10.2.5 Japan BCG Lab Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Serum Institute of India Tuberculosis Vaccine Drug Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 AJ Vaccines
10.4.1 AJ Vaccines Company Information
10.4.2 AJ Vaccines Introduction and Business Overview
10.4.3 AJ Vaccines Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 AJ Vaccines Tuberculosis Vaccine Drug Products Offered
10.4.5 AJ Vaccines Recent Development
10.5 BioFarma
10.5.1 BioFarma Company Information
10.5.2 BioFarma Introduction and Business Overview
10.5.3 BioFarma Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 BioFarma Tuberculosis Vaccine Drug Products Offered
10.5.5 BioFarma Recent Development
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Company Information
10.6.2 GreenSignal Bio Pharma Introduction and Business Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Products Offered
10.6.5 GreenSignal Bio Pharma Recent Development
10.7 China National Biotec
10.7.1 China National Biotec Company Information
10.7.2 China National Biotec Introduction and Business Overview
10.7.3 China National Biotec Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 China National Biotec Tuberculosis Vaccine Drug Products Offered
10.7.5 China National Biotec Recent Development
10.8 Biomed Lublin
10.8.1 Biomed Lublin Company Information
10.8.2 Biomed Lublin Introduction and Business Overview
10.8.3 Biomed Lublin Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Biomed Lublin Tuberculosis Vaccine Drug Products Offered
10.8.5 Biomed Lublin Recent Development
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Company Information
10.9.2 Taj Pharmaceuticals Introduction and Business Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Products Offered
10.9.5 Taj Pharmaceuticals Recent Development
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Company Information
10.10.2 Ataulpho de Paiva Introduction and Business Overview
10.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Products Offered
10.10.5 Ataulpho de Paiva Recent Development
10.11 IVAC
10.11.1 IVAC Company Information
10.11.2 IVAC Introduction and Business Overview
10.11.3 IVAC Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 IVAC Tuberculosis Vaccine Drug Products Offered
10.11.5 IVAC Recent Development
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Company Information
10.12.2 Queen Saovabha Mem. Inst Introduction and Business Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Products Offered
10.12.5 Queen Saovabha Mem. Inst Recent Development
10.13 Microgen
10.13.1 Microgen Company Information
10.13.2 Microgen Introduction and Business Overview
10.13.3 Microgen Tuberculosis Vaccine Drug Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Microgen Tuberculosis Vaccine Drug Products Offered
10.13.5 Microgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tuberculosis Vaccine Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tuberculosis Vaccine Drug Industrial Chain Analysis
11.4 Tuberculosis Vaccine Drug Market Dynamics
11.4.1 Tuberculosis Vaccine Drug Industry Trends
11.4.2 Tuberculosis Vaccine Drug Market Drivers
11.4.3 Tuberculosis Vaccine Drug Market Challenges
11.4.4 Tuberculosis Vaccine Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tuberculosis Vaccine Drug Distributors
12.3 Tuberculosis Vaccine Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Immune Vaccine
Table 2. Major Company of Therapy Vaccine
Table 3. Global Tuberculosis Vaccine Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (K Units)
Table 5. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US& Million)
Table 7. Global Tuberculosis Vaccine Drug Market Share in Value by Type (2024-2024)
Table 8. Global Tuberculosis Vaccine Drug Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Tuberculosis Vaccine Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Tuberculosis Vaccine Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Tuberculosis Vaccine Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Tuberculosis Vaccine Drug Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (K Units)
Table 15. North America Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Tuberculosis Vaccine Drug Sales (K Units) by Type (2024-2024)
Table 17. Europe Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Tuberculosis Vaccine Drug Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Tuberculosis Vaccine Drug Sales (K Units) by Type (2024-2024)
Table 21. Latin America Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Tuberculosis Vaccine Drug Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Tuberculosis Vaccine Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Tuberculosis Vaccine Drug Sales by Company (2024-2024) & (K Units)
Table 25. Global Tuberculosis Vaccine Drug Sales Share by Company (2024-2024)
Table 26. Global Tuberculosis Vaccine Drug Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Tuberculosis Vaccine Drug Revenue Share by Company (2024-2024)
Table 28. Global Market Tuberculosis Vaccine Drug Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Tuberculosis Vaccine Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Tuberculosis Vaccine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Tuberculosis Vaccine Drug Market
Table 33. Key Manufacturers Tuberculosis Vaccine Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Tuberculosis Vaccine Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Tuberculosis Vaccine Drug Sales by Region (2024-2024) & (K Units)
Table 37. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Tuberculosis Vaccine Drug Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Tuberculosis Vaccine Drug Sales Market Share in Value by Region (2024-2024)
Table 40. Global Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Tuberculosis Vaccine Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Tuberculosis Vaccine Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Tuberculosis Vaccine Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Tuberculosis Vaccine Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (K Units)
Table 48. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Tuberculosis Vaccine Drug Sales Market Share in Value by Application (2024-2024)
Table 51. Global Tuberculosis Vaccine Drug Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Tuberculosis Vaccine Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Tuberculosis Vaccine Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Tuberculosis Vaccine Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Tuberculosis Vaccine Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Tuberculosis Vaccine Drug Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Tuberculosis Vaccine Drug Sales by Application (2024-2024) (K Units)
Table 58. North America Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Tuberculosis Vaccine Drug Sales by Application (2024-2024) (K Units)
Table 60. Europe Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Tuberculosis Vaccine Drug Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Tuberculosis Vaccine Drug Sales by Application (2024-2024) (K Units)
Table 64. Latin America Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Tuberculosis Vaccine Drug Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Tuberculosis Vaccine Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (K Units)
Table 68. North America Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2024)
Table 71. North America Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (K Units)
Table 76. Europe Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Tuberculosis Vaccine Drug Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Tuberculosis Vaccine Drug Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Tuberculosis Vaccine Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Tuberculosis Vaccine Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Tuberculosis Vaccine Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Merck Tuberculosis Vaccine Drug Product
Table 111. Merck Recent Development
Table 112. Japan BCG Lab Company Information
Table 113. Japan BCG Lab Introduction and Business Overview
Table 114. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Japan BCG Lab Tuberculosis Vaccine Drug Product
Table 116. Japan BCG Lab Recent Development
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Introduction and Business Overview
Table 119. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Serum Institute of India Tuberculosis Vaccine Drug Product
Table 121. Serum Institute of India Recent Development
Table 122. AJ Vaccines Company Information
Table 123. AJ Vaccines Introduction and Business Overview
Table 124. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. AJ Vaccines Tuberculosis Vaccine Drug Product
Table 126. AJ Vaccines Recent Development
Table 127. BioFarma Company Information
Table 128. BioFarma Introduction and Business Overview
Table 129. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. BioFarma Tuberculosis Vaccine Drug Product
Table 131. BioFarma Recent Development
Table 132. GreenSignal Bio Pharma Company Information
Table 133. GreenSignal Bio Pharma Introduction and Business Overview
Table 134. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product
Table 136. GreenSignal Bio Pharma Recent Development
Table 137. China National Biotec Company Information
Table 138. China National Biotec Introduction and Business Overview
Table 139. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. China National Biotec Tuberculosis Vaccine Drug Product
Table 141. China National Biotec Recent Development
Table 142. Biomed Lublin Company Information
Table 143. Biomed Lublin Introduction and Business Overview
Table 144. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Biomed Lublin Tuberculosis Vaccine Drug Product
Table 146. Biomed Lublin Recent Development
Table 147. Taj Pharmaceuticals Company Information
Table 148. Taj Pharmaceuticals Introduction and Business Overview
Table 149. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product
Table 151. Taj Pharmaceuticals Recent Development
Table 152. Ataulpho de Paiva Company Information
Table 153. Ataulpho de Paiva Introduction and Business Overview
Table 154. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Ataulpho de Paiva Tuberculosis Vaccine Drug Product
Table 156. Ataulpho de Paiva Recent Development
Table 157. IVAC Company Information
Table 158. IVAC Introduction and Business Overview
Table 159. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. IVAC Tuberculosis Vaccine Drug Product
Table 161. IVAC Recent Development
Table 162. Queen Saovabha Mem. Inst Company Information
Table 163. Queen Saovabha Mem. Inst Introduction and Business Overview
Table 164. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product
Table 166. Queen Saovabha Mem. Inst Recent Development
Table 167. Microgen Company Information
Table 168. Microgen Introduction and Business Overview
Table 169. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Microgen Tuberculosis Vaccine Drug Product
Table 171. Microgen Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Tuberculosis Vaccine Drug Market Trends
Table 175. Tuberculosis Vaccine Drug Market Drivers
Table 176. Tuberculosis Vaccine Drug Market Challenges
Table 177. Tuberculosis Vaccine Drug Market Restraints
Table 178. Tuberculosis Vaccine Drug Distributors List
Table 179. Tuberculosis Vaccine Drug Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccine Drug Product Picture
Figure 2. Global Tuberculosis Vaccine Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tuberculosis Vaccine Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Tuberculosis Vaccine Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Immune Vaccine
Figure 6. Global Immune Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Therapy Vaccine
Figure 8. Global Therapy Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Tuberculosis Vaccine Drug Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Tuberculosis Vaccine Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Tuberculosis Vaccine Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Tuberculosis Vaccine Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Tuberculosis Vaccine Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Tuberculosis Vaccine Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Tuberculosis Vaccine Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Tuberculosis Vaccine Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Vaccine Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Vaccine Drug Revenue in 2022
Figure 23. Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Self-Procurement
Figure 25. Global Self-Procurement Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of UNICEF
Figure 27. Global UNICEF Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Tuberculosis Vaccine Drug Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Tuberculosis Vaccine Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Tuberculosis Vaccine Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Tuberculosis Vaccine Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Tuberculosis Vaccine Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Tuberculosis Vaccine Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Tuberculosis Vaccine Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Tuberculosis Vaccine Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Tuberculosis Vaccine Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Tuberculosis Vaccine Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Tuberculosis Vaccine Drug Manufacturing Cost Structure
Figure 43. Tuberculosis Vaccine Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries